Adaptive Biotechnologies Corp (NASDAQ:ADPT) has coverage initiated with a Outperform rating

ME Staff
-
0

Analyst Ratings For Adaptive Biotechnologies Corp (NASDAQ:ADPT)

Today, Cowen initiated coverage on Adaptive Biotechnologies Corp (NASDAQ:ADPT) with a Outperform.

There are 4 Buy Ratings, 1 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on Adaptive Biotechnologies Corp (NASDAQ:ADPT) is Buy with a consensus target price of N/A per share, a potential N/A.

Some recent analyst ratings include

  • 7/22/2019-Adaptive Biotechnologies Corp (NASDAQ:ADPT) has coverage initiated with a Outperform rating
  • 7/22/2019-Adaptive Biotechnologies Corp (NASDAQ:ADPT) has coverage initiated with a Buy rating
  • 7/22/2019-Adaptive Biotechnologies Corp (NASDAQ:ADPT) has coverage initiated with a Buy rating
  • 7/22/2019-Adaptive Biotechnologies Corp (NASDAQ:ADPT) has coverage initiated with a Overweight rating
  • 7/22/2019-Adaptive Biotechnologies Corp (NASDAQ:ADPT) has coverage initiated with a Neutral rating

    Recent Trading Activity for Adaptive Biotechnologies Corp (NASDAQ:ADPT)
    Shares of Adaptive Biotechnologies Corp closed the previous trading session at 38.53 up +0.52 1.37% with shares trading hands.